Taysha Gene Therapies, Inc. (TSHA) — Net Income

Annual figures by fiscal year, from SEC filings.

2020: -$60.01M2021: -$174.52M2022: -$166.01M2023: -$111.57M2024: -$89.30M2025: -$109.00M-$109.00M
2020Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$109.00M-22.1%
2024-$89.30M+20.0%
2023-$111.57M+32.8%
2022-$166.01M+4.9%
2021-$174.52M-190.8%
2020-$60.01M